 Home > Active Ingredient News > Infection > NEJM: Investigation on Infection Status of California Medical Staff After Vaccination of SARS-CoV-2

NEJM: Investigation on Infection Status of California Medical Staff After Vaccination of SARS-CoV-2

 Last Update: 2021-03-30
 Source: Internet
 Author: User

Tags

clindamycin skin care

testing standards

Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

The New England Journal published a newsletter article on the investigation of the infection status of California medical staff after being vaccinated with SARS-CoV-2 .

New England Journal of Infection

As of November 2020, data from the third phase of clinical trials of mRNA vaccines show that 14 days after the second dose of mRNA-1273 vaccine (Moderna), the effective rate of preventing symptomatic SARS-CoV-2 infection is 94.

Prevention of COVID-19 FDA

Since the start of the vaccination campaign, there have been reports of new coronary pneumonia among people who received one or two doses of the vaccine .

Infected with new coronary pneumonia

From December 16, 2020 to February 9, 2021, a total of 36,659 medical staff received the first dose of vaccine, of which 28,184 (77%) received the second dose.

The absolute risk of testing positive for SARS-CoV-2 after vaccination is 1.

The agency conducts regular tests on asymptomatic and symptomatic people.

The effectiveness of the vaccine remains unchanged outside the test environment.

ncbi.

Leave a message here

This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

Related Products

Gansiclovir CAS 82410-32-0

CAS No.: 82410-32-0

Pharmaceutical Grade

$100/KG EXW

Lomefloxacin hydrochloride CAS 98079-52-8

CAS No.: 98079-52-8

Pharmaceutical Grade

$100/KG EXW

Levofloxacin mesylate CAS 226578-51-4

CAS No.: 226578-51-4

Pharmaceutical Grade

$100/KG EXW

Hot Tags

united states jobs(223)

jobs united states(236)

1 year treasury(277)

1 year subscription(296)

single use technology(195)

announcements today(81)

ups united states(221)

united states logo(227)

80 20 company(94)

healthy food name(42)

Hot Articles

The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.